Business
True Nature Expands Board, Appoints Senior Pharma Executive
True Nature Expands Board, Appoints Senior Pharma Executive.
About this update from Mitesco, Inc.
[{"type":"text","content":"\n \n \n True Nature Expands Board, Appoints Senior Pharma Executive\n \n \nTrue Nature Expands Board, Appoints Senior Pharma Executive\n \n ATLANTA, GA--(Marketwired - Feb 28, 2017) - True Nature Holding, Inc. (OTCQB: TNTY) (the \"Company\") announced that it has appointed Mr. James C. Czirr to its Board of Directors, effective immediately.\n Mr. Czirr, age 63, is a seasoned public company executive with experience in both early stage and established companies. He lends his vast business and pharmaceutical expertise to the Board of Directors, fortifying the Company's ability to build shareholder value through the consolidation of compounding pharmacy businesses. Of note, Czirr is the managing member of an investment fund focused on the strategic financing of emerging pharmaceutical businesses.\n With the addition of Mr. Czirr, True Nature's Board of Directors has grown to four members. \"Jim brings a depth of public company experience as well as a targeted pharmaceutical industry perspective, and we will undoubtedly benefit from his ability to skillfully represent the Company to the public and to investors,\" said Amy Lance, Chairman of the Board of Directors.\n Mr. Czirr stated; \"I believe the True Nature Holding strategy is well-timed and represents a rapid growth opportunity in a marketplace shifting toward consolidation.\" He continued, \"The acquisition and roll-up of compounding pharmaceutical operations per the Company's business model makes sense economically in a time of price sensitivity to the rising costs of drug development, distribution and regulation.\"\n Mr. James C. Czirr, also known as \"Jim,\" served as the Chief Executive Officer of Minerva Biotechnologies Corp. Mr. Czirr served as the President of Extol Energy Corporation, a syndicator of oil and gas wells from 1982 to 1988. He served as both a member of the board and Executive Vice President of Business Development at Pro Pharmaceuticals Inc. (AKA Galectin Therapeutics, Inc.) from June 2000 to November 2003. He was an Independent Corporate and Public Relations Consultant for over ten years, working with various companies regarding business strategies, including issues such as organization of production, finance and capital programs, marketing strategies and incentive programs. In 2009, Mr. Czirr organized the 10X Fund LP to provide turnaround financing fo...